Gelatin-Sealed Dacron Graft is not more Susceptible to MRSA Infection than PTFE Graft

European Journal of Vascular and Endovascular Surgery

Volumn 32, Issue 4, 2006, Pages 425-430

  Yasim, A ^a   Gul, M ^b   Ciralik, H ^c   Ergun, Y ^d  

^a Cardiovasc Surg Dept at T   (Turkey)

^b Microbiology

^c Pathology ^*

^d KAHRAMANMARAS SUTCU IMAM UNIVERSITY   (Turkey)

Author keywords

Dacron; PTFE; Susceptibility to infection; Vascular graft infection

Indexed keywords

ANTIINFECTIVE AGENT; GELATIN; METICILLIN; TEICOPLANIN;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COUNT; BACTERIUM ADHERENCE; BACTERIUM CONTAMINATION; BLOOD CULTURE; BLOOD SAMPLING; CONTROLLED STUDY; DACRON VASCULAR PROSTHESIS; DEVICE REMOVAL; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; GRAFT INFECTION; HISTOPATHOLOGY; INFECTION RISK; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLITEF IMPLANT; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTHESIS INFECTION; RAT; STAPHYLOCOCCUS INFECTION; SUBCUTANEOUS TISSUE;

ANIMALS; BLOOD; BLOOD VESSEL PROSTHESIS; BLOOD VESSEL PROSTHESIS IMPLANTATION; FEMALE; GELATIN; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; POLYETHYLENE TEREPHTHALATES; POLYTETRAFLUOROETHYLENE; PROSTHESIS-RELATED INFECTIONS; RATS; RATS, SPRAGUE-DAWLEY; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 33748435080     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2006.03.014     Document Type: Article

References (17)

1. Vicaretti M., Hawthorne W.J., Ao P.Y., and Fletcher J.P. An increased concentration of rifampicin bonded to gelatin-sealed Dacron reduces the incidence of subsequent graft infections following a staphylococcal challenge. Cardiovasc Surg 6 (1998) 268-273
2. Hernandez-Richter T., Schardey H.M., Witmann F., et al. Rifampin and Triclosan but not silver is effective in preventing bacterial infection of vascular Dacron graft material. Eur J Vasc Endovasc Surg 26 (2003) 550-557
3. Henke P.K., Bergamini T.M., Watson A.L., Brittian K.R., Powell D.W., and Peyton J.C. Bacterial products primary mediate fibroblast inhibition in biomaterial infection. J Surg Res 74 (1998) 17-22
4. Schmitt D.D., Bandyk D.F., Pequet A.J., and Towne J.B. Bacterial adherence to vascular prostheses. A determinant of graft infectivity. J Vasc Surg 3 (1986) 732-740
5. Post S., Kraus T., Muller-Reinartz U., et al. Dacron vs polytetrafluoroethylene grafts for femoropopliteal bypass: a prospective randomised multicentre trial. Eur J Vasc Endovasc Surg 22 (2001) 226-231
6. AbuRahma A.F., Hannay R.S., Khan J.H., Robinson P.A., Hudson J.K., and Davis E.A. Prospective randomized study of carotid endarterectomy with polytetrafluoroethylene versus collagen-impregnated Dacron (Hemashield) patching: perioperative (30-day) results. J Vasc Surg 35 (2002) 125-130
7. Bond R., Rerkasem K., Naylor A.R., AbuRahma A.F., and Rothwell P.M. Systematic review of randomized controlled trials of patch angioplasty versus primary closure and different type of patch materials during carotid endarterectomy. J Vasc Surg 40 (2004) 1126-1135
8. Chandy T., Das G.S., Wilson R.F., and Rao G.H.R. Use of plasma glow for surface-engineering biomolecules to enhance bloodcompatibility of Dacron and PTFE vascular prosthesis. Biomaterials 21 (2000) 699-712
9. Devine C., and McCollum C. Heparin-bounded Dacron or polytetrafluoroethylene for femoropopliteal bypass: Five-year results of a prospective randomized multicenter clinical trial. J Vasc Surg 40 (2004) 924-931
10. Giacometti A., Cirioni R., Ghiselli R., et al. Efficacy of polycationic peptides in preventing vascular graft infection due to Staphylococcus epidermidis. J Antimicrob Chemother 46 (2000) 751-756
11. Hernandez-Richter T., Schardey H.M., Lohlein F., et al. The prevention and treatment of vascular graft infection with a Triclosan (Irgasan)-bonded Dacron graft: an experimental study in the pig. Eur J Vasc Endovasc Surg 20 (2000) 413-418
12. Zeltman D., Tzarnas C.D., and Kerstein M.D. Management of vascular prosthetic infections: results of long-term follow-up. Am Surg 65 (1999) 331-333
13. Prager M.R., Hoblaj T., Nanobashvili J., et al. Collagen-versus gelatine-coated Dacron versus stretch PTFE bifurcation grafts for aortoiliac occlusive disease: long-term results of a prospective, randomized multicenter trial. Surgery 134 (2003) 80-85
14. Cintora I., Pearce D.E., and Cannon J.A. A clinical survey of aortobifemoral bypass using two different graft types. Ann Surg 208 (1998) 625-630
15. Camiade C., Goldschmidt P., Koskas F., et al. Optimization of the resistance of arterial allografts to infection: comparative study with synthetic prostheses. Ann Vasc Surg 15 (2001) 186-196
16. Jones L., Braithwaite B.D., Davies B., Heather B.P., and Earnshaw J.J. Mechanism of late prosthetic vascular graft infection. Cardiovasc Surg 5 (1997) 486-489
17. Chiesa R., Melissano G., Castellano R., and Frigerio S. Extensible expanded polytetrafluoroethylene vascular grafts for aortoiliac and aortofemoral reconstruction. Cardiovasc Surg 8 (2000) 538-544